Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone

BACKGROUND: Surgical resection with curative intent for giant cell tumor of bone (GCTB) may be associated with severe morbidity. This interim analysis evaluated reduction in surgical invasiveness after denosumab treatment in patients with resectable GCTB. METHODS: Patients with primary or recurrent...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Surg Oncol
Main Authors: Rutkowski, Piotr, Ferrari, Stefano, Grimer, Robert J., Stalley, Paul D., Dijkstra, Sander P. D., Pienkowski, Andrzej, Vaz, Gualter, Wunder, Jay S., Seeger, Leanne L., Feng, Amy, Roberts, Zachary J., Bach, Bruce A.
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2015
Assuntos:
Bone and Soft Tissue Sarcomas
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531146/
https://ncbi.nlm.nih.gov/pubmed/26033180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4634-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares